# Itopride in Functional Dyspepsia:a Dose Finding Study

> **NCT00272103** · PHASE2,PHASE3 · COMPLETED · sponsor: **Royal Adelaide Hospital** · enrollment: 500 (—)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** Itopride (drug)

## Key facts

- **NCT ID:** NCT00272103
- **Lead sponsor:** Royal Adelaide Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-12
- **Primary completion:** —
- **Final completion:** 2002-01
- **Target enrollment:** 500 (—)
- **Last updated:** 2006-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00272103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00272103, "Itopride in Functional Dyspepsia:a Dose Finding Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00272103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*